Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Cellectar Biosciences, Inc.
Emory University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Baylor College of Medicine
St. Jude Children's Research Hospital
Hoffmann-La Roche
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seattle Children's Hospital
Seattle Children's Hospital
Memorial Sloan Kettering Cancer Center
Instituto do Cancer do Estado de São Paulo
Bambino Gesù Hospital and Research Institute
Pfizer